Cervical Cancer Screening Recommendations: Now and for the Future.

cervical cancer screening

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
11 Aug 2023
Historique:
received: 31 05 2023
revised: 08 07 2023
accepted: 01 08 2023
medline: 26 8 2023
pubmed: 26 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

Cervical cancer is the fourth most common cancer worldwide, with over 600,000 new cases annually and approximately 350,000 cancer-related deaths per year. The disease burden is disproportionately distributed, with cancer-related mortality ranging from 5.2 deaths per 100,000 individuals in highly-developed countries, to 12.4 deaths per 100,000 in less-developed countries. This article is a review of the current screening recommendations and potential future recommendations.

Identifiants

pubmed: 37628471
pii: healthcare11162273
doi: 10.3390/healthcare11162273
pmc: PMC10454304
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

BMJ. 2018 Dec 5;363:k4823
pubmed: 30518635
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Acta Dermatovenerol Croat. 2006;14(3):208
pubmed: 17010274
J Community Health. 2017 Aug;42(4):770-778
pubmed: 28155005
J Natl Cancer Inst. 2013 Oct 16;105(20):1550-7
pubmed: 24096620
J Pathol. 1999 Sep;189(1):12-9
pubmed: 10451482
Health Technol Assess. 2004 May;8(20):iii, 1-78
pubmed: 15147611
World J Clin Oncol. 2015 Dec 10;6(6):281-90
pubmed: 26677441
J Obstet Gynaecol India. 2018 Jun;68(3):232-235
pubmed: 29896006
Int J Cancer. 2006 Sep 1;119(5):1095-101
pubmed: 16586444
J Low Genit Tract Dis. 2021 Jul 1;25(3):187-191
pubmed: 34138787
Lancet Glob Health. 2021 Feb;9(2):e161-e169
pubmed: 33212031
Prev Med. 2020 Jun;135:106076
pubmed: 32247010
Chin J Cancer Res. 2020 Dec 31;32(6):720-728
pubmed: 33446995
Taiwan J Obstet Gynecol. 2019 May;58(3):345-348
pubmed: 31122522
N Engl J Med. 2021 Nov 11;385(20):1908-1918
pubmed: 34758259
BMJ. 2022 May 31;377:e068776
pubmed: 35640960
Int J Cancer. 2012 Apr 15;130(8):1879-87
pubmed: 21607948
Asian Pac J Cancer Prev. ;18(6):1461-1467
pubmed: 28669152
CMAJ. 2022 May 2;194(17):E613-E615
pubmed: 35500920
N Engl J Med. 2003 Oct 16;349(16):1501-9
pubmed: 14561792
Lancet Glob Health. 2019 Jun;7(6):e772-e783
pubmed: 31097279
N Engl J Med. 2015 Feb 19;372(8):711-23
pubmed: 25693011
Front Oncol. 2020 Oct 02;10:533253
pubmed: 33123463
Cochrane Database Syst Rev. 2011 May 11;(5):CD002834
pubmed: 21563135
BMJ. 2019 Oct 22;367:l5825
pubmed: 31640984
Front Public Health. 2021 Jan 20;8:552028
pubmed: 33553082
Cureus. 2020 Dec 26;12(12):e12293
pubmed: 33520497
Prev Med. 2022 Jul;160:107096
pubmed: 35594924
Med Clin North Am. 2015 May;99(3):469-77
pubmed: 25841595
JCO Glob Oncol. 2022 Sep;8:e2200217
pubmed: 36162041
Int J Cancer. 2014 Jul 15;135(2):453-66
pubmed: 24338632
BMJ. 2016 Oct 4;355:i4924
pubmed: 27702796
Lancet. 2019 Jan 12;393(10167):169-182
pubmed: 30638582
Patient Prefer Adherence. 2015 Mar 24;9:501-8
pubmed: 25848229
BMC Cancer. 2017 Nov 25;17(1):791
pubmed: 29178896
JAMA Netw Open. 2022 Jan 4;5(1):e2143582
pubmed: 35040970
J Natl Cancer Inst. 2021 Jan 4;113(1):72-79
pubmed: 32584382
N Engl J Med. 2003 Feb 6;348(6):518-27
pubmed: 12571259
PLoS Med. 2008 Jun 17;5(6):e132
pubmed: 18563963
Lancet Glob Health. 2022 Sep;10(9):e1336-e1346
pubmed: 35878625
Int J Cancer. 2009 Feb 1;124(3):516-20
pubmed: 18973271
Clin Microbiol Infect. 2021 Aug;27(8):1083-1095
pubmed: 33975008
Int J Cancer. 2020 Sep 1;147(5):1275-1285
pubmed: 31970767
Oman Med J. 2020 Apr 30;35(2):e122
pubmed: 32411417
J Obstet Gynaecol. 2020 Jul;40(5):602-608
pubmed: 31500479
Can J Public Health. 2013 Feb 11;104(2):e159-66
pubmed: 23618210
Int J Cancer. 2007 Jul 15;121(2):361-7
pubmed: 17354241
Lancet Glob Health. 2020 Feb;8(2):e171-e172
pubmed: 31981548
BMJ. 2008 Oct 13;337:a1754
pubmed: 18852164
J Infect Dis. 2010 Dec 15;202(12):1789-99
pubmed: 21067372
Pan Afr Med J. 2021 Sep 20;40:48
pubmed: 34795828
BMJ Open. 2017 Jun 11;7(6):e016282
pubmed: 28606908
Front Microbiol. 2018 Nov 28;9:2896
pubmed: 30546351
Lancet Oncol. 2010 Mar;11(3):249-57
pubmed: 20089449
Cleve Clin J Med. 2019 Mar;86(3):173-178
pubmed: 30849035
J Lab Physicians. 2017 Apr-Jun;9(2):104-110
pubmed: 28367025
BMJ Open. 2023 Jan 6;13(1):e065074
pubmed: 36609331
Lancet. 2014 Feb 8;383(9916):524-32
pubmed: 24192252
CA Cancer J Clin. 2020 Sep;70(5):321-346
pubmed: 32729638
Prev Med Rep. 2022 May 08;28:101813
pubmed: 35637896
Cancer Sci. 2007 Oct;98(10):1505-11
pubmed: 17645777
Gynecol Oncol. 2022 Aug;166(2):358-368
pubmed: 35781165
Indian J Cancer. 2018 Jan-Mar;55(1):80-83
pubmed: 30147099
Clin Microbiol Rev. 2003 Jan;16(1):1-17
pubmed: 12525422
JAMA Oncol. 2019 Feb 1;5(2):181-186
pubmed: 30325982
Front Med (Lausanne). 2022 Nov 17;9:1006038
pubmed: 36465901
J Glob Oncol. 2018 Sep;4:1-9
pubmed: 30241249

Auteurs

Marissa Rayner (M)

Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, VA 22908, USA.

Annalyn Welp (A)

Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, VA 22908, USA.

Mark H Stoler (MH)

Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, VA 22908, USA.

Leigh A Cantrell (LA)

Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, VA 22908, USA.

Classifications MeSH